10x Genomics Inc (TXG)
26.30
-0.26
(-0.98%)
USD |
NASDAQ |
May 15, 15:15
10x Genomics Cash from Investing (Quarterly): 10.63M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 10.63M |
| December 31, 2023 | 13.10M |
| September 30, 2023 | 4.90M |
| June 30, 2023 | -4.462M |
| March 31, 2023 | 119.96M |
| December 31, 2022 | -33.17M |
| September 30, 2022 | -32.63M |
| June 30, 2022 | -27.53M |
| March 31, 2022 | -257.56M |
| December 31, 2021 | -27.62M |
| September 30, 2021 | -20.23M |
| Date | Value |
|---|---|
| June 30, 2021 | -14.57M |
| March 31, 2021 | -44.32M |
| December 31, 2020 | -22.27M |
| September 30, 2020 | -1.31M |
| June 30, 2020 | -6.739M |
| March 31, 2020 | -8.079M |
| December 31, 2019 | -6.581M |
| September 30, 2019 | -13.68M |
| June 30, 2019 | -13.14M |
| March 31, 2019 | -9.367M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-257.56M
Minimum
Mar 2022
119.96M
Maximum
Mar 2023
-19.26M
Average
-13.41M
Median
Cash from Investing (Quarterly) Benchmarks
| Teladoc Health Inc | -35.51M |
| American Shared Hospital Services | -0.097M |
| Novo Integrated Sciences Inc | -- |
| Astrana Health Inc | -71.04M |
| Cryo-Cell International Inc | -0.341M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -15.72M |
| Cash from Financing (Quarterly) | 1.638M |
| Free Cash Flow | -73.95M |
| Free Cash Flow Per Share (Quarterly) | -0.1561 |
| Free Cash Flow to Equity (Quarterly) | -18.64M |
| Free Cash Flow to Firm (Quarterly) | -18.64M |
| Free Cash Flow Yield | -2.38% |